Gross Margin
5.19%vs Specialty Chemicals peers Provider-reported. Gross Profit (TTM) ÷ Revenue (TTM) on this page gives -8.83%.Updated Nov 20, 2026Profit Margin
-21.92%vs Specialty Chemicals peers Updated Nov 20, 2026Operating Margin
-18.23%vs Specialty Chemicals peers Updated Nov 20, 2026Return on Assets (TTM)
-1.28%vs Specialty Chemicals peers Updated Nov 20, 2026Return on Equity (TTM)
-4.13%vs Specialty Chemicals peers Updated Nov 20, 2026Revenue (TTM)
14.20BTWD431.03M · vs all stocks (USD) Updated Nov 20, 2026Revenue per Share (TTM)
3.75TWDUpdated Nov 20, 2026Quarterly Revenue Growth
-35.80%vs Specialty Chemicals peers Updated Nov 20, 2026Gross Profit (TTM)
-1.25BTWD-38.04M · vs all stocks (USD) Updated Nov 20, 2026EBITDA (TTM)
-1.21BTWD-36.82M · vs all stocks (USD) Updated Nov 20, 2026Net Income (TTM)
-3.08BTWD-93.49M · vs all stocks (USD) Updated Nov 20, 2026Quarterly Earnings Growth (YoY)
-20.70%vs Specialty Chemicals peers Updated Nov 20, 2026Operating Cash Flow (TTM)
-868.96MTWD-26.38M · vs all stocks (USD) Updated Nov 20, 2026Payout Ratio
0.00%vs Specialty Chemicals peers Updated Nov 20, 2026Minority Interest (Equity)
56.37MTWDFY2025 · Dec 31, 2025Revenue
19.22BTWDFY2025 · Dec 31, 2025Cost of Goods Sold
21.06BTWDFY2025 · Dec 31, 2025Gross Profit
-1.84BTWDFY2025 · Dec 31, 2025Operating Income
-3.57BTWD-108.30M · vs all stocks (USD) FY2025 · Dec 31, 2025Pre-tax Income
-2.48BTWDFY2025 · Dec 31, 2025Income Tax Expense
266.28MTWDFY2025 · Dec 31, 2025Net Income
-2.99BTWDFY2025 · Dec 31, 2025EBIT
-1.78BTWDFY2025 · Dec 31, 2025EBITDA (Income Statement)
-232.65MTWDFY2025 · Dec 31, 2025Research & Development
233.07MTWDFY2025 · Dec 31, 2025Selling, General & Administrative
1.50BTWDFY2025 · Dec 31, 2025Non-operating Interest Income
114.15MTWDFY2025 · Dec 31, 2025Non-operating Interest Expense
692.20MTWDFY2025 · Dec 31, 2025EPS (Basic)
-0.7800TWDFY2025 · Dec 31, 2025EPS (Diluted)
-0.7800TWDFY2025 · Dec 31, 2025Basic Shares Outstanding
3.78BSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
3.78BSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
-2.72BTWDFY2025 · Dec 31, 2025Minority Interests (P&L)
23.12MTWDFY2025 · Dec 31, 2025Preferred Stock Dividends
0.00TWDFY2025 · Dec 31, 2025Operating Cash Flow
23.84MTWDFY2025 · Dec 31, 2025Free Cash Flow
17.03MTWDFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
1.82BTWDFY2025 · Dec 31, 2025Starting Profit (CF Statement)
-2.72BTWDFY2025 · Dec 31, 2025Other Non-cash Items
906.51MTWDFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
1.12BTWDFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
725.16MTWDFY2025 · Dec 31, 2025Capital Expenditures
-6.80MTWDFY2025 · Dec 31, 2025Net Intangibles (CF)
-5.43MTWDFY2025 · Dec 31, 2025Net Acquisitions
691.52MTWDFY2025 · Dec 31, 2025Purchase of Investments
-35.10MTWDFY2025 · Dec 31, 2025Sale of Investments
1.13BTWDFY2025 · Dec 31, 2025Other Investing Activity
1.68BTWDFY2025 · Dec 31, 2025Net Investing Cash Flow
3.46BTWDFY2025 · Dec 31, 2025Long-term Debt Issuance
67.55BTWDFY2025 · Dec 31, 2025Long-term Debt Payments
-71.63BTWDFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-1.61BTWDFY2025 · Dec 31, 2025Other Financing Charges
-19.11MTWDFY2025 · Dec 31, 2025Net Financing Cash Flow
-5.71BTWDFY2025 · Dec 31, 2025